Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFiB inflammatory pathway

Vascular Pharmacology

Volumn 73, Issue , 2015, Pages 115-123

  Bihl, Ji C ^a   Zhang, Cheng ^a   Zhao, Yuhui ^a   Xiao, Xiang ^a   Ma, Xiaotang ^b   Chen, Yusen ^b   Chen, Shuzhen ^a   Zhao, Bin ^b   Chen, Yanfang ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Ang II; Ang (1 7); Hemorrhagic stroke; NF B; VSMCs

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN I; ANGIOTENSIN I (1-7); AUTACOID; CYTOKINE; G PROTEIN COUPLED RECEPTOR; NEUROPROTECTIVE AGENT; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN INJURY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENDOTHELIUM CELL; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL HEMORRHAGES; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION MEDIATORS; INTRACRANIAL HEMORRHAGES; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VASCULAR REMODELING; WOUND HEALING;

EID: 84941736926     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.08.007     Document Type: Article

References (48)

1. Guo Y.J., Li W.H., Wu R., Xie Q., Cui L.Q. ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages. Arch. Med. Res. Feb 2008, 39(2):149-154.
2. Regenhardt R.W., Bennion D.M., Sumners C. Cerebroprotective action of angiotensin peptides in stroke. Clin. Sci. (Lond.) Feb 2014, 126(3):195-205.
3. Mecca A.P., Regenhardt R.W., O'Connor T.E., Joseph J.P., Raizada M.K., Katovich M.J., et al. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. Oct 2011, 96(10):1084-1096.
4. Regenhardt R.W., Mecca A.P., Desland F., Ritucci-Chinni P.F., Ludin J.A., Greenstein D., et al. Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats. Exp. Physiol. Feb 2014, 99(2):442-453.
5. Chen J., Zhao Y., Chen S., Wang J., Xiao X., Ma X., et al. Neuronal over-expression of ACE2 protects brain from ischemia-induced damage. Neuropharmacology Apr 2014, 79:550-558.
6. Chang S., Song S., Lee J., Yoon J., Park J., Choi S., et al. Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate. PLoS One 2014, 9(2):e88089.
7. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. Apr 2007, 39(2):86-93.
8. Starke R.M., Chalouhi N., Ding D., Raper D.M., Mckisic M.S., Owens G.K., et al. Vascular smooth muscle cells in cerebral aneurysm pathogenesis. Translat. Stroke Res. Jun 2014, 5(3):338-346.
9. Lim S., Park S. Role of vascular smooth muscle cell in the inflammation of atherosclerosis. BMB Rep. Jan 2014, 47(1):1-7.
10. Daugherty A., Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc. Med. Apr 2004, 14(3):117-120.
11. Starke R.M., Raper D.M., Ding D., Chalouhi N., Owens G.K., Hasan D.M., et al. Tumor necrosis factor-alpha modulates cerebral aneurysm formation and rupture. Translat. Stroke Res. Apr 2014, 5(2):269-277.
12. Bhatt S.R., Lokhandwala M.F., Banday A.A. Vascular oxidative stress upregulates angiotensin II type I receptors via mechanisms involving nuclear factor kappa B. Clin. Exp. Hypertens. 2014, 36(6):367-373.
13. Colie S., Pecher C., Girolami J.P., Blaes N. Modulation by bradykinin and nitric oxide of angiotensin II-induced apoptosis in a vascular smooth muscle cell phenotype. Int. Immunopharmacol. Feb 2008, 8(2):231-236.
14. Ruiz E., Redondo S., Padilla E., Gordillo-Moscoso A., Salaices M., Balfagon G., et al. Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan. Eur. J. Pharmacol. Jul 19 2007, 567(3):231-239.
15. Gu S., Zhang W., Chen J., Ma R., Xiao X., Ma X., et al. EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis. PLoS One 2014, 9(1):e85396.
16. Jarajapu Y.P., Bhatwadekar A.D., Caballero S., Hazra S., Shenoy V., Medina R., et al. Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors. Diabetes Apr 2013, 62(4):1258-1269.
17. Yaghini F.A., Song C.Y., Lavrentyev E.N., Ghafoor H.U., Fang X.R., Estes A.M., et al. Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension Jun 2010, 55(6):1461-1467.
18. da Costa Goncalves A.C., Fontes M.A., Klussmann E., Qadri F., Janke J., Gollasch M., et al. Spinophilin regulates central angiotensin II-mediated effect on blood pressure. J. Mol. Med. (Berl.) Dec 2011, 89(12):1219-1229.
19. Yang J.M., Dong M., Meng X., Zhao Y.X., Yang X.Y., Liu X.L., et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler. Thromb. Vasc. Biol. Aug 2013, 33(8):1978-1985.
20. Chang C.F., Chen S.F., Lee T.S., Lee H.F., Chen S.F., Shyue S.K. Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage. Am. J. Pathol. Apr 2011, 178(4):1749-1761.
21. Wang J., Tsirka S.E. Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain Jul 2005, 128(Pt 7):1622-1633.
22. Clark W., Gunion-Rinker L., Lessov N., Hazel K. Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke Oct 1998, 29(10):2136-2140.
23. Zhu W., Gao Y., Chang C.F., Wan J.R., Zhu S.S., Wang J. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 2014, 9(5):e97423.
24. Chen J., Chen S., Chen Y., Zhang C., Wang J., Zhang W., et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. Am. J. Physiol. Endocrinol. Metab. Jul 2011, 301(1):E62-E71.
25. Marquez-Martin A., Jimenez-Altayo F., Dantas A.P., Caracuel L., Planas A.M., Vila E. Middle cerebral artery alterations in a rat chronic hypoperfusion model. J. Appl. Physiol. Feb 2012, 112(3):511-518.
26. Foerch C., Arai K., Jin G., Park K.P., Pallast S., van L K., et al. Experimental model of warfarin-associated intracerebral hemorrhage. Stroke Dec 2008, 39(12):3397-3404.
27. Elijovich L., Patel P.V., Hemphill J.C. Intracerebral hemorrhage. Semin. Neurol. Nov 2008, 28(5):657-667.
28. Miller A.A., Budzyn K., Sobey C.G. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin. Sci. (Lond.) Jul 2010, 119(1):1-17.
29. Zhang F., Hu Y., Xu Q., Ye S. Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS One 2010, 5(8):e12323.
30. Patel V.B., Clarke N., Wang Z., Fan D., Parajuli N., Basu R., et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J. Mol. Cell. Cardiol. Jan 2014, 66:167-176.
31. Lu J., Jiang T., Wu L., Gao L., Wang Y., Zhou F., et al. The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides Oct 2013, 47(5):289-295.
32. Kagiyama T., Kagiyama S., Phillips M.I. Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul. Pept. Feb 28 2003, 110(3):241-247.
33. Collister J.P., Hendel M.D. The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J. Renin Angiotensin Aldosterone Syst. Sep 2003, 4(3):176-179.
34. Benter I.F., Yousif M.H., Anim J.T., Cojocel C., Diz D.I. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am. J. Physiol. Heart Circ. Physiol. Feb 2006, 290(2):H684-H691.
35. Walters P.E., Gaspari T.A., Widdop R.E. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension May 2005, 45(5):960-966.
36. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. Feb 2007, 292(2):H736-H742.
37. Zeng W., Chen W., Leng X., He J.G., Ma H. Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits. Biochem. Biophys. Res. Commun. Nov 6 2009, 389(1):138-144.
38. Langeveld B., van Gilst W.H., Tio R.A., Zijlstra F., Roks A.J. Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat. Hypertension Jan 2005, 45(1):138-141.
39. Lusis A.J. Atherosclerosis. Nature Sep 14 2000, 407(6801):233-241.
40. Koenig J.B., Jaffe I.Z. Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications. Curr. Hypertens. Rep. May 2014, 16(5):427.
41. Pena Silva R.A., Kung D.K., Mitchell I.J., Alenina N., Bader M., Santos R.A., et al. Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice. Hypertension Aug 2014, 64(2):362-368.
42. Chen S., Ding Y., Tao W., Zhang W., Liang T., Liu C. Naringenin inhibits TNF-alpha induced VSMC proliferation and migration via induction of HO-1. Food Chem. Toxicol. Sep 2012, 50(9):3025-3031.
43. Lee D., Lee K.H., Park H., Kim S.H., Jin T., Cho S., et al. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice. PLoS One 2013, 8(8):e69669.
44. Zahradka P., Werner J.P., Buhay S., Litchie B., Helwer G., Thomas S. NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells. J. Mol. Cell. Cardiol. Dec 2002, 34(12):1609-1621.
45. Ebrahimian T., Li M.W., Lemarie C.A., Simeone S.M., Pagano P.J., Gaestel M., et al. Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress. Hypertension Feb 2011, 57(2):245-254.
46. Sriramula S., Cardinale J.P., Lazartigues E., Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc. Res. Dec 1 2011, 92(3):401-408.
47. Giani J.F., Munoz M.C., Pons R.A., Cao G., Toblli J.E., Turyn D., et al. Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. Jan 2011, 300(1):F272-F282.
48. Moore E.D., Kooshki M., Metheny-Barlow L.J., Gallagher P.E., Robbins M.E. Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radic. Biol. Med. Dec 2013, 65:1060-1068.